Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BP-Stroke: Intensive BP Lowering in Acute Ischemic Stroke
NCT03443596Phase 3Completed
- Sponsor
- National University of Singapore
- Start
- Dec 2014
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of labetalol in ischemic stroke, sponsored by National University of Singapore. Started Dec 2014; status: completed.
02
Drugs
labetalol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03443596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03443596.